Injecting drug use is a risk factor for deep vein thrombosis in women in Glasgow

被引:51
作者
McColl, MD [1 ]
Tait, RC
Greer, IA
Walker, ID
机构
[1] Crosshouse Hosp, Dept Haematol, Ayrshire & Arran Acute Hosp NHS Trust, Kilmarnock KA2 0BE, Scotland
[2] Royal Infirm, Dept Haematol, Glasgow G31 2ER, Lanark, Scotland
[3] Royal Infirm, Univ Dept Obstet & Gynaecol, Glasgow G31 2ER, Lanark, Scotland
关键词
deep vein thrombosis; injecting drug use; venous thromboembolism; pulmonary embolism;
D O I
10.1046/j.1365-2141.2001.02633.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Three hundred and twenty-two consecutive women aged 16-70 years who presented with objectively confirmed symptomatic venous thromboembolism (VTE) were studied to determine precipitating factors for thrombosis. One hundred and eighty-seven presented with deep vein thrombosis (DVT), 116 with either definite or possible pulmonary embolism (PE) and 19 with both DVT and PE. Injecting drug use (IDU) via femoral vein puncture was a common risk factor for DVT, associated with 21.4% of all cases of DVT and 52.4% of cases of DVT in women under 40 years. All women with drug-related thrombosis presented with DVT. None presented with symptomatic PE. A number of clinically diagnosed DVT associated with IDU were also documented, suggesting that IDU may be the most common risk factor for DVT in our region. DVT associated with IDU presents significant management challenges.
引用
收藏
页码:641 / 643
页数:3
相关论文
共 9 条
[1]   Risk of venous thromboembolism in users of hormone replacement therapy [J].
Daly, E ;
Vessey, MP ;
Hawkins, MN ;
Carson, JL ;
Gough, P ;
Marsh, S .
LANCET, 1996, 348 (9033) :977-980
[2]  
FARLEY TMM, 1995, LANCET, V346, P1582
[3]   Population-based study of risk of venous thromboembolism associated with various oral contraceptives [J].
Farmer, RDT ;
Lawrenson, RA ;
Thompson, CR ;
Kennedy, JG ;
Hambleton, IR .
LANCET, 1997, 349 (9045) :83-88
[4]   Prospective study of exogenous hormones and risk of pulmonary embolism in women [J].
Grodstein, F ;
Stampfer, MJ ;
Goldhaber, SZ ;
Manson, JE ;
Colditz, GA ;
Speizer, FE ;
Willett, WC ;
Hennekens, CH .
LANCET, 1996, 348 (9033) :983-987
[5]   Hormone replacement therapy and risk of venous thromboembolism: Population based case-control study [J].
Gutthann, SP ;
Rodriguez, LAG ;
Castellsague, J ;
Oliart, AD .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 314 (7083) :796-800
[6]  
Labropoulos N., 1996, J VASCULAR TECHNOLOG, V20, P27
[7]  
MAKOWER RM, 1992, ARCH EMERG MED, V9, P32
[8]  
McColl MD, 1997, THROMB HAEMOSTASIS, V78, P1183
[9]  
POULTER NR, 1995, LANCET, V346, P1575